The Susan G. Komen Breast Cancer Foundation, INC. DBA Susan G. Komen

Based in TX

🤖

AI Overview

With $2.5M in lobbying spend across 32 quarterly filings, The Susan G. Komen Breast Cancer Foundation, INC. DBA Susan G. Komen is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2018 to 2025.

$2.5M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
6
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$320K
2019$330K
2020$230K
2021$250K
2022$270K
2023$300K
2024$310K
2025$490K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Insurance, Medicare/Medicaid, Defense and 1 more

  • H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients.
  • H.R.930/S.497, Lymphe
  • H.R.1625 - Vehicle for Consolidated Appropriations Act 2018 - issues related to cancer prevention, screening and research funding.
  • FY2019 Labor, Health and Human Services and Education Appropriation
  • H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;
  • H.R.1676/S.693, Palliative Care and Hospice Educatio
  • H.R.1409, Cancer Drug Parity Act of 2017, advocate for equitable coverage of cancer therapies;
  • H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies;
  • H.R.4978, Chronic
  • FY2019 Labor, Health and Human Services and Education Appropriations Bill - issues related to cancer prevention, screening and research funding.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.